Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin cardiovascular outcomes study in type 2 diabetes after acute coronary syndrome
2009-011222-34Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Alogliptin + standard of care with Placebo + standard of care (2 arms). Started Aug 2009; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-011222-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011222-34.